Bioxytran Market Cap

Bioxytran has a market cap or net worth of $3.85 million as of April 29, 2026. Its market cap has decreased by -76.59% in one year.

Market Cap

3.85M

Enterprise Value

4.63M

Revenue

n/a

Ranking

n/a

PE Ratio

n/a

Stock Price

$0.03

Market Cap Chart

Since September 24, 2018, Bioxytran's market cap has decreased from 25.52M to 3.85M, a decrease of -84.93%. That is a compound annual growth rate of -22.05%.

Market Cap History

Date	Market Cap	% Change
Apr 28, 2026	3.85M	-52.83%
Dec 31, 2025	8.15M	4.49%
Dec 31, 2024	7.80M	-64.29%
Dec 29, 2023	21.85M	-63.00%
Dec 30, 2022	59.05M	33.18%
Dec 31, 2021	44.34M	89.57%
Dec 30, 2020	Pro	Pro
Dec 30, 2019	Pro	Pro
Dec 31, 2018	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
GPL Holdings	4.17M
AccuStem Sciences	4.50M
Nymox Pharmaceutical	4.85M
Oncology Pharma	2.90M
Mosaic ImmunoEngineering	5.40M
CASI Pharmaceuticals	2.71M
Institute of Biomedical Research	5.50M
Burzynski Research Institute	2.55M

Market Cap Rankings